Veeva Systems Is Still a Biotech and Pharmaceuticals Industry Best Buy After Q3 Results [The Motley Fool]
Veeva Systems Inc. Class A (VEEV)
Last veeva systems inc. class a earnings: 3/3 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.veeva.com/investors/investor-overview/default.aspx
Company Research
Source: The Motley Fool
Veeva Systems Is Still a Biotech and Pharmaceuticals Industry Best Buy After Q3 Results This healthcare software company plays a pivotal role in the development of new drugs and treatments. If you're a biotech and pharmaceutical stock dummy like myself, picking individual stocks in the specialized space can be incredibly high risk. As Warren Buffett once said, "Risk comes from not knowing what you're doing." Yet there are ways to get in on the industry besides just buying a biotech or healthcare ETF . One way is Veeva Systems ( NYSE:VEEV ) , which just issued another solid report card for its fiscal 2020 third quarter. As the biotech industry continues to grow and digital transformation among businesses spread, this software company is a great bet without needing to know the ins and outs of drug development. Veeva's Q3 revenue topped guidance it provided a few months prior, coming in 25% higher than a year ago at $281 million. Outpacing growth in expenses, adjusted net income for the
Show less
Read more
Impact Snapshot
Event Time:
VEEV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VEEV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VEEV alerts
High impacting Veeva Systems Inc. Class A news events
Weekly update
A roundup of the hottest topics
VEEV
News
- Veeva Stock May Gain on the Launch of GenAI Features in Vault CRM [Yahoo! Finance]Yahoo! Finance
- Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims [Yahoo! Finance]Yahoo! Finance
- Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and ClaimsPR Newswire
- Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and ClaimsPR Newswire
- Veeva Commercial Summit: Increased investment in medical affairs by pharma companies [Yahoo! Finance]Yahoo! Finance
VEEV
Earnings
- 8/28/24 - Beat
VEEV
Sec Filings
- 11/12/24 - Form 4
- 11/8/24 - Form 144
- 11/8/24 - Form 8-K
- VEEV's page on the SEC website